Diabetes: Page 9

  • Ypsomed's YpsoPump for diabetes management
    Image attribution tooltip
    Courtesy of Ypsomed
    Image attribution tooltip

    Ypsomed seeks new partner for US insulin pump launch as Lilly quits deal

    The companies planned to launch a customized version of the YpsoPump that used pre-filled insulin cartridges for Lilly’s rapid-acting insulins.

    By • Dec. 12, 2022
  • The Dexcom G7 Continuous Glucose Monitor
    Image attribution tooltip
    Courtesy of Dexcom
    Image attribution tooltip

    Dexcom’s G7 glucose monitor wins awaited FDA clearance

    The new Dexcom monitor is expected to generate significant patient demand, as it has been cleared by the FDA for patients with Type 1 and Type 2 diabetes, as well as gestational diabetes.

    By • Dec. 8, 2022
  • A visiting nurse helps a patient at home with CGM monitoring
    Image attribution tooltip
    Phynart Studio/Getty via Getty Images
    Image attribution tooltip

    AI detects prediabetes in CGM data, opening up new use for device: study

    By correctly identifying many patients with prediabetes or Type 2 diabetes, researchers say CGMs can be used to prevent the disease. 

    By • Dec. 6, 2022
  • Team of surgeons operating on patient in hospital - stock photo Four doctors in hospital operating room with patient lying on operating table. Surgical lights shining on medical team performing operat
    Image attribution tooltip
    Johnny Greig via Getty Images
    Image attribution tooltip

    The 10 biggest medtech stories of 2022

    MedTech Dive reporting this year has explored how companies maintained momentum even amid supply shortages and rising inflation rates.

    By MedTech Dive staff • Dec. 3, 2022
  • Professional photo of Dev Kurdikar
    Image attribution tooltip
    Permission granted by Embecta
    Image attribution tooltip
    Q&A

    Friday Q&A: Embecta CEO talks BD spinoff, future of diabetes devices

    Dev Kurdikar spoke with MedTech Dive about developing an insulin pump for patients with Type 2 diabetes and what’s next for the firm.

    By • Nov. 18, 2022
  • A patient being examined for retinal problems related to diabetes
    Image attribution tooltip
    Courtesy of AEYE Health
    Image attribution tooltip

    AEYE Health wins FDA clearance for AI-powered eye test to expand diabetic screening

    Approval is a first step to letting primary care physicians use a hand-held camera backed by AI to diagnose potential diabetic-related sight issues.

    By • Nov. 18, 2022
  • A person sits in front of a plate of food, holding a smartphone. They're wearing a patch on their left arm.
    Image attribution tooltip
    Courtesy of Insulet Corp.
    Image attribution tooltip

    Insulet warns Omnipod 5 insulin pump charge issue may cause fire

    Rapid sales growth at the company has come amid safety problems involving some of its devices.

    By • Nov. 17, 2022
  • A Medtronics diabetes device
    Image attribution tooltip
    Courtesy of https://news.medtronic.com/MiniMed-R-670G-Hybrid-Closed-Loop-System#assets_34137_21-122
    Image attribution tooltip

    Medtronic doubles wear time of insulin pump infusion sets

    The company calculated users of its extended-wear system will change their devices 75 fewer times, resulting in annual savings of more than $1,000.

    By • Nov. 16, 2022
  • Tandem Diabetes Control-IQ
    Image attribution tooltip
    Courtesy of Tandem Diabetes
    Image attribution tooltip

    Tandem pump, paired with Dexcom CGM, boosts blood glucose control in Type 2 diabetics

    Patients with Type 2 diabetes spent 3.6 hours per day longer in the target blood glucose range after switching to Tandem’s system, a study found.

    By • Nov. 14, 2022
  • A Lilly Tempo diabetes device
    Image attribution tooltip
    Courtesy of Eli Lilly
    Image attribution tooltip

    Lilly’s new diabetes management platform to integrate Dexcom CGM

    The launch comes seven years after the company began investing in device R&D to counter pricing pressures.

    By • Nov. 9, 2022
  • A woman lifting her shirt to expose her midriff and show a Verily Onduo CGM
    Image attribution tooltip
    Courtesy of Verily
    Image attribution tooltip

    Verily’s Onduo cut blood sugar in retrospective study of Type 2 diabetics

    Participants with high blood sugar at baseline benefited the most from Onduo, a study found.

    By • Nov. 8, 2022